Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan Berlin

Showing results (51-60 of 148) with videos related to

Pageof 15
Sort By:
Cancer|August 3, 2007
Panitumumab monotherapy in patients with previously treated metastatic colorectal cancerJ Randolph Hecht, Amita Patnaik, Jordan Berlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Phase I and pharmacokinetic study of a micronized formulation of carboxyamidotriazole, a calcium signal transduction inhibitor: toxicity, bioavailability and the effect of foodJordan Berlin, Kendra D Tutsch, Rhoda Z Arzoomanian, et al.
Journal of Surgical Oncology|August 25, 2005
Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumabFrank A Scappaticci, Louis Fehrenbacher, Thomas Cartwright, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2010
Lack of correlation between epidermal growth factor receptor status and response to Panitumumab monotherapy in metastatic colorectal cancerJ Randolph Hecht, Edith Mitchell, Marcus A Neubauer, et al.
The Oncologist|April 12, 2023
Management of Patients With Pancreatic Cancer Using the "Right Track" ModelAllison Rosenzweig, Jordan Berlin, Suresh Chari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2013
Changing the way we do business: recommendations to accelerate biomarker development in pancreatic cancerMargaret A Tempero, David Klimstra, Jordan Berlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Phase I clinical and pharmacokinetic study of oral penclomedine (NSC 338720) in adults with advanced solid malignancyGlenn Liu, Jordan Berlin, Kendra D Tutsch, et al.
JCO Oncology Practice|June 30, 2023
Factors and Barriers to Goals-of-Care Conversations for Patients With Cancer and Inpatient MortalityMargaret Wheless, Julie J Lee, Henry J Domenico, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2016
A phase 1b study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: an Academic Oncology GI Cancer Consortium studySteven J Cohen, Bert H O'Neil, Jordan Berlin, et al.
The Oncologist|May 27, 2020
A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients with Stage IV Metastatic Pancreatic AdenocarcinomaMarc T Roth, Dana Backlund Cardin, Erkut Hasan Borazanci, et al.
Pageof 15

Showing results (51-60 of 148) with videos related to

Sort By:
Pageof 15
Cancer|August 3, 2007
Panitumumab monotherapy in patients with previously treated metastatic colorectal cancerJ Randolph Hecht, Amita Patnaik, Jordan Berlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Phase I and pharmacokinetic study of a micronized formulation of carboxyamidotriazole, a calcium signal transduction inhibitor: toxicity, bioavailability and the effect of foodJordan Berlin, Kendra D Tutsch, Rhoda Z Arzoomanian, et al.
Journal of Surgical Oncology|August 25, 2005
Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumabFrank A Scappaticci, Louis Fehrenbacher, Thomas Cartwright, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2010
Lack of correlation between epidermal growth factor receptor status and response to Panitumumab monotherapy in metastatic colorectal cancerJ Randolph Hecht, Edith Mitchell, Marcus A Neubauer, et al.
The Oncologist|April 12, 2023
Management of Patients With Pancreatic Cancer Using the "Right Track" ModelAllison Rosenzweig, Jordan Berlin, Suresh Chari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2013
Changing the way we do business: recommendations to accelerate biomarker development in pancreatic cancerMargaret A Tempero, David Klimstra, Jordan Berlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Phase I clinical and pharmacokinetic study of oral penclomedine (NSC 338720) in adults with advanced solid malignancyGlenn Liu, Jordan Berlin, Kendra D Tutsch, et al.
JCO Oncology Practice|June 30, 2023
Factors and Barriers to Goals-of-Care Conversations for Patients With Cancer and Inpatient MortalityMargaret Wheless, Julie J Lee, Henry J Domenico, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2016
A phase 1b study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: an Academic Oncology GI Cancer Consortium studySteven J Cohen, Bert H O'Neil, Jordan Berlin, et al.
The Oncologist|May 27, 2020
A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients with Stage IV Metastatic Pancreatic AdenocarcinomaMarc T Roth, Dana Backlund Cardin, Erkut Hasan Borazanci, et al.
Pageof 15